Concerta Guidance: Sub x Form inter­action vari­ance test [Regulatives / Guidelines]

posted by jag009  – NJ, 2014-12-05 21:57 (3401 d 17:28 ago) – Posting: # 13991
Views: 13,870

Hi everyone,

Question regarding the sub*Form interaction variance test required for Concerta draft guidance...

"Subject-by-formulation interaction variance, σ2D2I-0.5*(σ2wt + σ2wr)

In Step 4..."As per APPENDIX A in the FDA 2001 bioequivalence guidance, the recommended allowance for σ2D is 0.03."


They are referring to σ2D value being no greater than 0.03 right? Can the number be negative, i.e, -0.06?

Thanks
John
Thread locked

Complete thread:

UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,636 registered users;
112 visitors (0 registered, 112 guests [including 6 identified bots]).
Forum time: 15:26 CET (Europe/Vienna)

With four parameters I can fit an elephant,
and with five I can make him wiggle his trunk.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5